TOPICS

Tag: stage I cutaneous melanoma

Risk Stratification of Patients with Stage I Cutaneous Melanoma Using 31-Gene Expression Profiling

J Clin Aesthet Dermatol. 2021;14(9):E61–E63. by Brian J. Martin, PhD; Kyle R. Covington, PhD; Ann P. Quick, PhD; and Robert W. Cook, PhD All authors are employees with Castle Biosciences, Inc. in Friendswood, Texas. FUNDING: This study was funded by Castle Biosciences, Inc. DISCLOSURES: All authors are employees with Castle Biosciences, Inc. in Friendswood, Texas.

CONTINUE READING »